PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Medpace Holdings, Inc. (MEDP)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINUS58506Q1094
CUSIP58506Q109
SectorHealthcare
IndustryDiagnostics & Research
IPO DateAug 11, 2016

Highlights

Market Cap$11.21B
EPS (TTM)$11.41
PE Ratio31.62
PEG Ratio1.72
Total Revenue (TTM)$2.07B
Gross Profit (TTM)$607.56M
EBITDA (TTM)$439.73M
Year Range$268.80 - $459.77
Target Price$355.25
Short %5.31%
Short Ratio2.87

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons: MEDP vs. SWAV, MEDP vs. PEN, MEDP vs. RACE, MEDP vs. MOH, MEDP vs. INMD, MEDP vs. ATEC, MEDP vs. AAPL, MEDP vs. CPRX, MEDP vs. KNSL, MEDP vs. QQQ

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Medpace Holdings, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-20.00%-10.00%0.00%10.00%JuneJulyAugustSeptemberOctoberNovember
-11.10%
12.73%
MEDP (Medpace Holdings, Inc.)
Benchmark (^GSPC)

Returns By Period

Medpace Holdings, Inc. had a return of 17.71% year-to-date (YTD) and 30.79% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date17.71%25.45%
1 month3.71%2.91%
6 months-9.46%14.05%
1 year30.79%35.64%
5 years (annualized)38.12%14.13%
10 years (annualized)N/A11.39%

Monthly Returns

The table below presents the monthly returns of MEDP, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-4.88%36.33%1.67%-3.91%-0.52%6.60%-7.12%-7.12%-6.04%-5.87%17.71%
20234.08%-12.30%-3.01%6.43%3.41%16.04%5.41%6.75%-10.41%0.22%11.56%13.23%44.31%
2022-18.46%-13.80%6.94%-18.35%7.24%4.49%13.27%-12.93%6.48%41.24%-5.45%1.20%-2.40%
2021-4.60%22.32%1.00%3.43%-1.54%5.73%-0.39%3.64%3.80%19.69%-8.45%4.93%56.35%
20201.77%5.13%-18.41%8.83%16.23%0.22%28.31%8.75%-13.90%-0.72%15.70%8.44%65.60%
201921.67%-14.67%7.32%-4.75%-3.90%21.19%20.39%2.73%3.87%-12.39%4.13%9.64%58.81%
20181.30%-12.74%8.92%5.96%13.98%1.99%42.72%-2.57%0.20%-13.04%18.83%-14.50%45.97%
2017-3.27%-17.02%3.11%6.23%-12.27%4.24%-5.41%18.99%-2.27%17.46%-11.10%8.86%0.53%
20160.75%5.70%-2.81%22.95%1.09%28.64%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of MEDP is 63, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of MEDP is 6363
Combined Rank
The Sharpe Ratio Rank of MEDP is 6464Sharpe Ratio Rank
The Sortino Ratio Rank of MEDP is 5757Sortino Ratio Rank
The Omega Ratio Rank of MEDP is 6161Omega Ratio Rank
The Calmar Ratio Rank of MEDP is 7373Calmar Ratio Rank
The Martin Ratio Rank of MEDP is 6161Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Medpace Holdings, Inc. (MEDP) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


MEDP
Sharpe ratio
The chart of Sharpe ratio for MEDP, currently valued at 0.78, compared to the broader market-4.00-2.000.002.004.000.78
Sortino ratio
The chart of Sortino ratio for MEDP, currently valued at 1.23, compared to the broader market-4.00-2.000.002.004.006.001.23
Omega ratio
The chart of Omega ratio for MEDP, currently valued at 1.19, compared to the broader market0.501.001.502.001.19
Calmar ratio
The chart of Calmar ratio for MEDP, currently valued at 0.99, compared to the broader market0.002.004.006.000.99
Martin ratio
The chart of Martin ratio for MEDP, currently valued at 2.35, compared to the broader market0.0010.0020.0030.002.35
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.90, compared to the broader market-4.00-2.000.002.004.002.90
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 3.87, compared to the broader market-4.00-2.000.002.004.006.003.87
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.54, compared to the broader market0.501.001.502.001.54
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 4.19, compared to the broader market0.002.004.006.004.19
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 18.72, compared to the broader market0.0010.0020.0030.0018.72

Sharpe Ratio

The current Medpace Holdings, Inc. Sharpe ratio is 0.78. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Medpace Holdings, Inc. with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.001.002.003.004.00JuneJulyAugustSeptemberOctoberNovember
0.78
2.90
MEDP (Medpace Holdings, Inc.)
Benchmark (^GSPC)

Dividends

Dividend History


Medpace Holdings, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-21.10%
-0.29%
MEDP (Medpace Holdings, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Medpace Holdings, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Medpace Holdings, Inc. was 42.87%, occurring on Apr 27, 2022. Recovery took 180 trading sessions.

The current Medpace Holdings, Inc. drawdown is 21.10%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-42.87%Dec 28, 202184Apr 27, 2022180Jan 13, 2023264
-41.43%Dec 7, 2016101May 3, 2017160Dec 19, 2017261
-39.47%Feb 26, 202016Mar 18, 202082Jul 15, 202098
-31.29%Jul 17, 202476Oct 31, 2024
-27.23%Jan 24, 202334Mar 13, 202376Jun 30, 2023110

Volatility

Volatility Chart

The current Medpace Holdings, Inc. volatility is 14.36%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%25.00%JuneJulyAugustSeptemberOctoberNovember
14.36%
3.86%
MEDP (Medpace Holdings, Inc.)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Medpace Holdings, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Valuation

The Valuation section provides an assessment of the market value of Medpace Holdings, Inc. compared to its peers in the Diagnostics & Research industry.


PE Ratio
50.0100.0150.0200.0250.0300.031.6
The chart displays the price to earnings (P/E) ratio for MEDP in comparison to other companies of the Diagnostics & Research industry. Currently, MEDP has a PE value of 31.6. This PE ratio falls in the average range for the industry.
PEG Ratio
-2.00.02.04.01.7
The chart displays the price to earnings to growth (PEG) ratio for MEDP in comparison to other companies of the Diagnostics & Research industry. Currently, MEDP has a PEG value of 1.7. This PEG ratio is much higher than those of other companies of the industry. This might be an indicator of the company being overvalued.

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Medpace Holdings, Inc..


Loading data...

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items